PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Hörber, S. ; Lehmann, R. ; Fritsche, L. ; Machann, J. ; Birkenfeld, A.L. ; Häring, H.-U. ; Stefan, N. ; Heni, M. ; Fritsche, A. ; Peter, A.

Lifestyle intervention improves prothrombotic coagulation profile in individuals at high-risk for type 2 diabetes.

J. Clin. Endocrinol. Metab. 106, E3198-E3207 (2021)
Publ. Version/Full Text Postprint DOI PMC
Open Access Green
AIMS: Patients with obesity and insulin resistance are at higher risk for arterial and venous thrombosis due to a prothrombotic state. If this is reversible by lifestyle intervention was addressed in the current study and potential underlying associations were elucidated. SUBJECTS AND METHODS: One-hundred individuals with impaired glucose tolerance or impaired fasting plasma glucose participated in a 1-year lifestyle intervention, including precise metabolic phenotyping and MRT-based determination of liver fat content as well as a comprehensive analysis of coagulation parameters before and after this intervention. RESULTS: During the lifestyle intervention significant reductions in coagulation factor activities (II, VII, VIII, IX, XI and XII) were observed. Accordingly, prothrombin time (PT%) and activated partial thromboplastin time (aPTT) were slightly decreased and prolonged, respectively. Moreover, PAI-1, vWF and also protein C and protein S decreased. Fibrinogen, antithrombin, D-Dimer and FXIII remained unchanged. Searching for potential regulators, especially weight loss, but also liver fat reduction, improved insulin sensitivity and decreased low-grade inflammation were linked to favorable changes in hemostasis parameters. INDEPENDENT OF WEIGHT LOSS: , liver fat reduction (FII, protein C, protein S, PAI-1, vWF), improved insulin sensitivity (protein S, PAI-1) and reduced low-grade inflammation (PT%, aPTT, FVIII/IX/XI/XII, vWF) were identified as single potential regulators. CONCLUSIONS: Lifestyle intervention is able to improve a prothrombotic state in individuals at high-risk for type 2 diabetes. Besides body weight, liver fat content, insulin sensitivity and systemic low-grade inflammation are potential mechanisms for improvements in hemostasis and could represent future therapeutic targets.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.958
1.948
2
3
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Prediabetes ; Fibrinolysis ; Hemostasis ; Lifestyle Intervention ; Thrombosis; Plasminogen-activator Inhibitor-1; Impaired Glucose-tolerance; Fatty Liver-disease; Plasma Pai-1 Levels; Adipose-tissue; Insulin-resistance; Venous Thromboembolism; Weight-loss; Procoagulant Imbalance; Improved Fibrinolysis
Language english
Publication Year 2021
HGF-reported in Year 2021
ISSN (print) / ISBN 0021-972X
e-ISSN 1945-7197
Journal Journal of Clinical Endocrinology & Metabolism, The
Quellenangaben Volume: 106, Issue: 8, Pages: E3198-E3207 Article Number: , Supplement: ,
Publisher Endocrine Society
Publishing Place Bethesda, Md.
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes Research and Metabolic Diseases (IDM)
POF-Topic(s) 90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502400-001
Grants German Center for Diabetes Research (DZD) - German Federal Ministry for Education and Research
DOI 10.1210/clinem/dgab124
WOS ID WOS:000753603800053
WOS ID WOS:000685227300053
PubMed ID 33659996
Erfassungsdatum 2021-04-27
[➜Report correction]